{"name":"Providence Health & Services","slug":"providence-health-services","ticker":"","exchange":"","domain":"providence.org","description":"Providence Health & Services is a not-for-profit Catholic healthcare system headquartered in Renton, Washington. The health system includes 51 hospitals, more than 800 non-acute facilities, and numerous assisted living facilities in the western half of the United States. Providence Health & Services was founded by the Sisters of Providence in 1859 and merged with St. Joseph Health in 2016.","hq":"Renton","founded":1859,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"Cell Infusion","genericName":"Cell Infusion","slug":"cell-infusion","indication":"Other","status":"phase_2"},{"name":"cetrizine","genericName":"cetrizine","slug":"cetrizine","indication":"Other","status":"marketed"},{"name":"Anti-OX40 antibody administration","genericName":"Anti-OX40 antibody administration","slug":"anti-ox40-antibody-administration","indication":"Other","status":"phase_1"},{"name":"INCAGN01876","genericName":"INCAGN01876","slug":"incagn01876","indication":"Other","status":"phase_2"},{"name":"Intratumoral Ipilimumab","genericName":"Intratumoral Ipilimumab","slug":"intratumoral-ipilimumab","indication":"Other","status":"phase_1"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"neuroscience","drugs":[{"name":"Continuation of insulin glargine","genericName":"Continuation of insulin glargine","slug":"continuation-of-insulin-glargine","indication":"Type 1 diabetes mellitus","status":"marketed"},{"name":"Switching to NPH insulin","genericName":"Switching to NPH insulin","slug":"switching-to-nph-insulin","indication":"Type 1 diabetes mellitus","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"INCMGA00012","genericName":"INCMGA00012","slug":"incmga00012","indication":"Advanced or metastatic melanoma","status":"phase_2"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"ACTH","genericName":"ACTH","slug":"acth","indication":"Adrenocortical insufficiency (primary and secondary)","status":"marketed"}]}],"pipeline":[{"name":"Cell Infusion","genericName":"Cell Infusion","slug":"cell-infusion","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"INCMGA00012","genericName":"INCMGA00012","slug":"incmga00012","phase":"phase_2","mechanism":"INCMGA00012 is an anti-CTLA-4 monoclonal antibody that blocks immune checkpoint inhibition to enhance T-cell activation and anti-tumor immunity.","indications":["Advanced or metastatic melanoma","Other solid tumors (in combination with checkpoint inhibitors)"],"catalyst":""},{"name":"cetrizine","genericName":"cetrizine","slug":"cetrizine","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ACTH","genericName":"ACTH","slug":"acth","phase":"marketed","mechanism":"ACTH (adrenocorticotropic hormone) stimulates the adrenal cortex to produce and release cortisol and other corticosteroids.","indications":["Adrenocortical insufficiency (primary and secondary)","Infantile spasms (West syndrome)","Rheumatoid arthritis","Systemic lupus erythematosus","Acute exacerbations of multiple sclerosis"],"catalyst":""},{"name":"Anti-OX40 antibody administration","genericName":"Anti-OX40 antibody administration","slug":"anti-ox40-antibody-administration","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Continuation of insulin glargine","genericName":"Continuation of insulin glargine","slug":"continuation-of-insulin-glargine","phase":"marketed","mechanism":"Insulin glargine is a long-acting basal insulin that binds to insulin receptors to lower blood glucose by promoting glucose uptake into cells and inhibiting hepatic glucose production.","indications":["Type 1 diabetes mellitus","Type 2 diabetes mellitus"],"catalyst":""},{"name":"INCAGN01876","genericName":"INCAGN01876","slug":"incagn01876","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Intratumoral Ipilimumab","genericName":"Intratumoral Ipilimumab","slug":"intratumoral-ipilimumab","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Switching to NPH insulin","genericName":"Switching to NPH insulin","slug":"switching-to-nph-insulin","phase":"marketed","mechanism":"NPH insulin is a long-acting basal insulin that binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels.","indications":["Type 1 diabetes mellitus","Type 2 diabetes mellitus"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPWGFMUlBKeHEyNlpYMHlsSC1HTnBabk1GWVZzMkYySTZwU0RsR3JLRWlTSUg4WHQ2alBKMXl0cFd3OHN1TlU5cXlBUXBIZWIzazJRMnFkUkItTWRCR2E2VkNzWlJhTS1fYk1ySThmV2lkVTJUUmNzRmhGMWx4Xy1nUFhJbFR5VlZFMmYzaHg5R2lCcmcwY1JjSTFzaw?oc=5","date":"2026-04-02","type":"deal","source":"National Today","summary":"SV Health Investors Acquires EpiVax - National Today","headline":"SV Health Investors Acquires EpiVax","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQTHFfOGREMEJYVDI4eHQ4S2h1bVpyWnVqc05obWxoM0lIZGdjNndhMzBrLVVRd1ZBeUhwT1V1a1pCRFRWWDJFdlQyYmN6bjQwbjRwT3l2RzZ0bVZYNUFPTm1xZDhVWTNyeHVUa3JGbXRuVlhOMm85RVdkbm1pZGp6c2hZczlTNm9SWWdlVjBydFNwaFJWaUpKR2hROUhEdnZFREdkeVZvSjBNN253V3c?oc=5","date":"2026-03-02","type":"pipeline","source":"The Business Journals","summary":"DOJ sides with Big Pharma in fight over Rhode Island drug discount law - The Business Journals","headline":"DOJ sides with Big Pharma in fight over Rhode Island drug discount law","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE00UVlOVXZPdjZzVHM2bkVpZXRQNHJSX1VQOE1lWkdod0RFNFV4bmxrRWJONE0tYkpINV80U3dOWnRsQVNubDdxY3JGMDAxY2c2X3ZTZmZ1UDhuVENWV2RiNDZ6aFRubHl4aGhlRWlyT2Q0dw?oc=5","date":"2026-01-25","type":"deal","source":"The Business Journals","summary":"Woonsocket-based CVS battles Congress, FTC and courts while positioning itself as healthcare reform partner - The Business Journals","headline":"Woonsocket-based CVS battles Congress, FTC and courts while positioning itself as healthcare reform partner","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE4zOU1zT01IMG93R2NSMVZZMUVTS0l6N1Bybksza0FjM2U4N2JILVllMWVuZjRNMlpZYjI1a1Q1YTNpN09lUWdWek9ENWUwbktFampnWkl2dU5iend4SW0ydDZVWFdWUmYweFc3bUVtS1R5WDFsdGc?oc=5","date":"2026-01-15","type":"earnings","source":"Modern Healthcare","summary":"JPM 2026, Day 4: Clover predicts a profit, plans tech investments - Modern Healthcare","headline":"JPM 2026, Day 4: Clover predicts a profit, plans tech investments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE96UXJZVmN0QW1yckJQLXVjOUd6ZUIxWllJbkswdnVJQ3dtVnQ5YUpRM1ZzTC1qT0pvWUZnNGJKQW1IWVhSQzdDdjJWekh4UU1Wa2tLYVJWakRZUmpQVV9tNC1BRGVnamc?oc=5","date":"2026-01-12","type":"pipeline","source":"Fierce Healthcare","summary":"JPM26, Day 1: Advocate Health, MGB tout integrations; Waystar rolls out agentic AI - Fierce Healthcare","headline":"JPM26, Day 1: Advocate Health, MGB tout integrations; Waystar rolls out agentic AI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gJBVV95cUxQUEtSaDZwR05hSlJKc21fVXU1cnhyaTF5cDl0cVJSSjFBekFIcTBwbk1hbXdRRnk3blkxLWJFLXJmdWpzeS1KMjk4eENuM1Y0RHk3VFFQMlR1dU1FekJGNHJfaWFGaHdkMC1nYVpVQ1lvalhOUHM1Z2M4SElfNGUya29MM1c2a1dyS2ZGSVlzeEE0d3hueW44V1VXVmlBMllmZlJoVUxDc1NMUHNQN2NNUWNKQUZidEhOVEcwbm9WbWk4ZVJzakRYNUFhSXlPUGZXZU1zRjRCMTRQT3JFbWQtT3p0enZoTTFNY0lNMnFqUThIUF9jX2dLTm9pYVpmZGxMNFVkTlpzZ2xSZ0p0TFBjTGRkb3FqblFfeG1mbHIzcTJ6UnFsSEMyVWMxQzk4T2JqSXBEOUN1RmJCbDFZdjZjbjBBR0JzWV9kQWgxU2VNOXlOZw?oc=5","date":"2025-11-19","type":"pipeline","source":"KOMO","summary":"Providence Swedish announces cuts to workforce, a clinic, and pharmacy amid restructuring - KOMO","headline":"Providence Swedish announces cuts to workforce, a clinic, and pharmacy amid restructuring","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPQ3FjZFZjOWpHRHhQVlR4bV9HdE1LMjVtWE5OQXV6Qnp5QVM4RWNjaUkxQ2sxUXhIMlFBbWxTcDR6T2hPdjBzcXJMQTN0cnZPVWowamxWSlJUQURUMGlvNFh2aFY2NFFqeS1DSk16aUd0cngyelpkX2tZaVIzRWVhdTlsV09YYXhlSDd5blRRbVpjelN2am10T0JHOW56MnJMalE?oc=5","date":"2025-11-19","type":"pipeline","source":"Fierce Healthcare","summary":"Providence cutting around 450 positions in Washington, Oregon - Fierce Healthcare","headline":"Providence cutting around 450 positions in Washington, Oregon","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFBTNG5XMVZhRnZzU3ZIRDhPeGE4MmVWWjlERUNUbk9RXzlMTGpacmpuNG5yMElHOE9DNWxDVjE5eUVROEluUFFEejVYUXlMVHp2d205YlVmZmhnY2tGVXJxQkFzZlFGc0NIMTRkNEo1QnFiU2lBdTU1UVdveFhkd9IBgwFBVV95cUxPTjBvOXhXMlp0OGxCVDVhSGhEMFhOeHBtSUtLN3BqU3EwTkdJMExVUkxSajVhMzFDSkNRQmtuVmFLUUhGM1V6azNwSXl2NzF5RFJVZ21OS2hxYndCUnRfS0xLZGZCYjZraGxOdWZob0o3RGlSSW91bWFTZmgwWlNfLVFsMA?oc=5","date":"2025-11-19","type":"pipeline","source":"FOX 13 Seattle","summary":"Providence Swedish announces layoffs for nearly 300 staff in Seattle area - FOX 13 Seattle","headline":"Providence Swedish announces layoffs for nearly 300 staff in Seattle area - FOX 13 Seattle","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOWHlkbFBqWGpBNmYwUzJrZGhKZTBtY3BQYzM5c3J6Rjc2UnBwYjlYLXJvRDRnalRCSlh0TjczdEtDNDBpSjZXeHhRYWZ6bEgwWmMtUEJUaS1wOVVRYkNNcnZROVI1VS1vdDZ0anlRTC1keU1vc3VKVTlqRXJtVWhTcS1mNzdUNmV3NGR6YThEU1BETW8yaFRyYzZEMjY?oc=5","date":"2025-11-19","type":"pipeline","source":"Modern Healthcare","summary":"Providence eliminates more than 400 positions in 2 states - Modern Healthcare","headline":"Providence eliminates more than 400 positions in 2 states","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxNVE85OVRYY2JKRTFCLXdvbzZaTk8ta2VMeDlEUDRFS2x6TFZESzNXMDl3WllxeXlvekpBYkdNa1FEX0FSQ3NaV3ZpRUYyMm5vbm5yQldIa0ZlbldBQld3VWtuWnJLUzRXRFh0MGNNdUdfajNCWC0yS1dPVHdSMnkzWjZ1MlRnbHlZbXlpem5hMGdEbXY5dE9LT0kwRk91dDh1cW5yemFtYndjb3VFaWtUNXU4SDdGbnVwbWpMWk03MmpZallFRUE3QVR3WWRNTzViNXJadUF0Yw?oc=5","date":"2025-11-18","type":"pipeline","source":"KING5.com","summary":"Providence Swedish to cut 296 positions, citing financial challenges - KING5.com","headline":"Providence Swedish to cut 296 positions, citing financial challenges - KING5.com","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQZkRDNGRKdWZvRWxmUVpJQ2FSS0hMVGlRWG5qaGw0TmRfVVFLTUs0cWNBbFRlX2hVUGVUVjZocmpsTzVNamN1R2p0VmcxMDIzWmtMdUpUV2YybzZqSV9veDlOQWZFRFpDZjF3SHVPT1RpekV5Qi1tak1XNVZkWVg5bXFyc1lqWEFKNkFydzNxOXUxZ0MtSXljc1BzV2l3V0UyV3BWQw?oc=5","date":"2025-11-18","type":"pipeline","source":"The Seattle Times","summary":"Providence Swedish to eliminate nearly 300 positions - The Seattle Times","headline":"Providence Swedish to eliminate nearly 300 positions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5NWUVXLVpuRkNiYkJldkREcjZjdVhzVEswcGlSbi1RUG1NdG1vaTJWM0p0b0R6WDZNWG5XVE56bVE4TjBjTk5TZkJrVF9fdjFzNFdIN0dHUHVYVEN6VG9YUnJFNmF6WTQ?oc=5","date":"2025-11-18","type":"pipeline","source":"MyNorthwest.com","summary":"Providence Swedish to cut nearly 300 positions, citing ‘economic pressures’ - MyNorthwest.com","headline":"Providence Swedish to cut nearly 300 positions, citing ‘economic pressures’","sentiment":"neutral"}],"patents":[],"drugCount":9,"phaseCounts":{"phase_2":3,"marketed":4,"phase_1":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}